Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Breast Cancer × trastuzumab deruxtecan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 20 Neoplasm Metastasis 9 Stomach Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Colorectal Neoplasms 3 Brain Neoplasms 3 Adenocarcinoma 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Neoplasms 2 Meningeal Carcinomatosis 2 Esophageal Neoplasms 2 Breast Cancer With Brain Metastasis 2 Salivary Gland Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasm, Residual 1 HER2-positive Breast Cancer 1 HER2-negative Breast Cancer 1 HER2-mutant Non-Small Cell Lung Cancer 1 HER2-low Hormone Receptor Positive Breast Cancer 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Gastric Adenocarcinoma 1 Carcinoma 1 Breast Cancer Metastatic 1 Advanced Breast Cancer 1

Interventions

Fulvestrant 8 olaparib 4 Capecitabine 4 pyrotinib 3 Docetaxel 3 Vinorelbine 2 Trastuzumab 2 Letrozole 2 Alpelisib 2 vandetanib 1 trastuzumab deruxtecan 1 talazoparib 1 sacituzumab govitecan 1 neratinib 1 liposomal doxorubicin 1 exemestane 1 eribulin 1 dalpiciclib 1 ceralasertib 1 cediranib 1 capivasertib 1 abemaciclib 1 Tablets 1 Moxifloxacin 1 Goserelin 1 Everolimus 1 Dasatinib 1 Cyclophosphamide 1 Cisplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06486883 2026-03-02

PONTIAC

MedSIR

Phase 2 Recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡